BioWave®’s patented, high-frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve and blocking transmission of …

BioWave’s patented high frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve, blocking the transmission of …

BioWave’s patented high frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve, blocking the transmission of …

BioWave’s patented high frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve, blocking the transmission of …

BioWave’s patented high frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve, blocking the transmission of …

Each BioWave® percutaneous microneedle array electrode contains 1,014 micro-needles, each measuring 0.74 mm in length, designed to deliver high-frequency electrical stimulation directly …

BioWave’s patented high frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve, blocking the transmission of …

BioWave’s proprietary technology was developed and born in professional sports in conjunction with the New York Giants football team through a clinical study treating pain from acute and …

Please visit the Patient Portal page on biowave.com to learn more about BioWave products and browse our training videos, tips, and news. If you have any questions, please contact us at …

BioWave is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested …